GlassScriptPhysician profile
Amanda Lefort
NPI 1902278567
$4,538.76
in general payments reported to CMS, 2019-2025
8 companies · $905 in 2025
The $905 reported for 2025 was more than what 79% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $385 · 2023: $905 · 2024: $2,195 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,112 · Travel and Lodging: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,111.80 |
| Travel and Lodging | $894.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,661.32 | 2022-2025 | |
| Neuronetics, INC. | $1,659.95 | 2024-2025 | Neurostar Tms Therapy System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $884.43 | 2021-2025 | Caplyta |
| Axsome Therapeutics, INC. | $157.14 | 2024-2025 | Auvelity, Sunosi |
| Vanda Pharmaceuticals INC. | $85.01 | 2024-2025 | Fanapt, Hetlioz |
| Lundbeck LLC | $52.07 | 2024-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $20.55 | 2022 | |
| Ironshore Pharmaceuticals INC. | $18.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lefort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.